Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Medicines Company, a provider of acute care products, has reported a net loss of $4.2 million, or $0.08 per diluted share, for the fourth quarter of 2008, compared to a net income of $1.5 million, or $0.03 per diluted share, for the fourth quarter of 2007.
Subscribe to our email newsletter
Net loss for the year ended December 31, 2008 was $8.5 million, or $0.16 per diluted share, compared to a net loss of $18.3 million, or $0.35 per diluted share, for the year ended December 31, 2007.
For the fourth quarter of 2008, the company reported net revenue of $93.9 million, an increase of 30%, compared to $72.3 million for the corresponding period of 2007. For the year ended December 31, 2008, the company posted net revenue of $348.2 million, an increase of 35%, compared to $257.5 million for the year ended December 31, 2007.
Clive Meanwell, CEO of The Medicines Company, said: 2008 was another important year of building a global organization with a substantial portfolio of hospital critical care products. Strong revenue growth year on year continues to provide cash flow for us to invest in our future and we believe we are poised for further sustainable growth.